Table 2.
Patient | Age at PJI/Gender | BMI | Comorbidities | Primary Arthroplasty | Revision | Micro at Prior PJIa | Prior Suppressive ABX | Time to PJI, mob | Temporal Classification | Micro at Current PJI | No. of Specimens With Growth | Specimen Type |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 79/M | 25.8 | CAD, chronic LLE ulcer | L knee | … | … | … | 25.7 | Late | C. striatum | ≥2 | SF/IO |
2 | 91/M | 32.2 | CKD, obesity | L knee | Aseptic | … | MIN | 51.6 | Late | C. striatum | ≥2 | IO |
3 | 60/M | 32.3 | DM, obesity | R knee | … | … | … | 0.5 | Early | C. striatum | ≥2 | IO |
4 | 82/F | 36 | CAD, DM, CHF, PAD, CKD, obesity, R leg HL, R leg radiation therapy | R knee | Aseptic | … | … | 94.3 | Late | C. striatum | ≥2 | SF |
5 | 40/F | 34.6 | Teratologic right hip dislocation, obesity | R hip | Aseptic | … | … | 0.6 | Early | C. amycolatum | ≥2 | SF/IO |
6 | 59/M | 62 | CHF, obesity, RLE lymphedema | R knee | Septic-DAIR | S. marcescens | SXT | 36.5 | Late | C. jeikeium | 1 | IO |
7 | 75/M | 36.4 | CAD, obesity | L knee | Septic-2-stage | CoNS | … | 19.4 | Late | C. striatum | ≥2 | SF/IO |
8 | 58/F | 29.8 | CKD | R knee | Septic-DAIR | Negative | MIN | 11.8 | Delayed | C. striatum | ≥2 | SF/IO |
9 | 65/F | 37 | Liver cirrhosis, DM, CHF, chronic RLE ulcer, CKD, obesity | L knee | … | … | … | 33.4 | Late | C. striatum | 1 | SFc |
10 | 50/M | 21.9 | Klipperl-trenaunay syndrome, asplenia | L knee | … | … | … | 30.0 | Late | C. jeikeium | 1 | SF |
11 | 59/M | 42.4 | CAD, DM, CHF, chronic LLE ulcer, CKD, obesity | L knee | Septic-DAIR | MSSA | LEX | 31.8 | Late | C. striatum | ≥2 | SF/IO |
12 | 63/F | 20 | RA, Crohn’s disease, immunosuppressive medications | R hip | Septic-DAIR | P. mirabilis | … | 30.4 | Late | C. striatum | ≥2 | IO |
13 | 55/F | 25.5 | RA, Marfan syndrome, immunosuppressive medications | R knee | … | … | … | 12.2 | Late | C. jeikeium | 1 | IOd |
14 | 69/M | 32 | Obesity | L hip | Aseptic | … | … | 6.4 | Delayed | C. amycolatum | ≥2 | IO |
15 | 68/F | 33.5 | RA, Sjogren syndrome, obesity | R knee | … | … | … | 13.3 | Late | C. jeikeium | 1 | IOd |
16 | 57/M | 31.3 | DM, CKD, COPD, obesity, cerebellar ataxia, developmental delay | L hip | … | … | … | 9.7 | Delayed | C. striatum | ≥2 | SF/IO |
17 | 85/M | 27.9 | CAD, DM, metastatic colon CA | R knee | … | … | … | 8.2 | Delayed | C. striatum | ≥2 | SF/IO |
18 | 69/F | 26.1 | PAD, CKD, localized bladder CA, radiation to pelvis | R hip | … | … | … | 47.2 | Late | C. striatum | ≥2 | IO |
19 | 65/M | 42.8 | DM, CIDP, immunosuppressive medications, obesity | R knee | Septic-DAIR | C. striatum | … | 20.7 | Late | C. striatum | ≥2 | SF/IO |
20 | 51/F | NR | Breast CA | R knee | … | … | … | 5.2 | Delayed | C. striatum | 1 | SF |
Abbreviations: ABX, antibiotics; BMI, body mass index; CA, cancer; CAD, coronary artery disease; CHF, congestive heart failure; CIDP, chronic inflammatory demyelinating polyneuropathy; CKD, chronic kidney disease; CoNS, coagulase-negative staphylococci; DAIR, debridement, antibiotic, and implant retention; DM, diabetes mellitus; F, female; HL, Hodgkin’s lymphoma; IO, intraoperative; L, left; LEX, cephalexin; LLE, left lower extremity; M, male; MIN, minocycline; MSSA, methicillin-susceptible Staphylococcus aureus; NR, not reported; PAD, peripheral arterial disease; R, right; RA, rheumatoid arthritis; RLE, right lower extremity; SF, synovial fluid; SXT, trimethoprim-sulfamethoxazole.
Stands for prior PJI episodes affecting the same joint as current PJI.
Time from last arthroplasty surgery to current PJI.
Growth from broth only.
Prosthesis sonicate fluid culture.